Congestive Heart Failure
Our Vision is to keep cardiovascular patients out of the hospitals
Highlights of NICaS advantages:
- NICaS can effectively reduce heart failure admissions and readmissions back to the hospital
- NICaS is accurate, but more importantly, it is consistent
- NICaS takes the guesswork out of managing difficult patients with heart failure
- NICaS affords a comfort level for medication titration not previously seen in these patients
- NICaS will identify patients with impending heart failure before they decompensate allowing time to make necessary adjustments that will prevent the decompensation of inadequate delivery of oxygen and nutrients to the tissues of the body, which can be due to a pumping or a relaxing problem of the heart.
Heart failure affects over 6 million people in the United States with about 700,000 new cases annually. The majority of admissions to the hospitals for heart failure are, in fact, readmissions for heart failure. Approximately 22% of people discharged from the hospitals with heart failure will be readmitted within 30 days and approximately 50% will be readmitted within 6 months.
The reasons for the huge financial and functional burden of heart failure are many including an incomplete understanding of the pathophysiology of heart failure, misdiagnoses, suboptimal use of evidence-based therapies and lack of a clinically useful, accurate and consistent means of assessing one’s cardiovascular physiology in real-time.
NICaS could be just the solution to address all of these limitations.
From a clinical standpoint, NICaS is able to provide accurate (highly correlates with pulmonary artery catheter), consistent and real-time date of one’s cardiovascular physiology. This would facilitate the ability to improve our understanding of one’s cardiovascular state, provide a clue as to what is causing the current state and Heart Failure, facilitate titration of medication to more optimal levels and provide a mean of assessing one’s response to medication adjustments. When coupled with physician or nurse practitioner with a strong understanding of basic cardiovascular physiology, NICaS has the potential to revolutionize the management of both chronical and acute heart failure and to, more importantly, improve outcomes for patients with this dreaded syndrome. See Figure 1 for the physiology of oxygen delivery as can provided by NICaS
Heart Failure Patient in the community
A heart failure patient comes to his cardiologists for a routine checkup. NICaS inspection reveals low contractility and high afterload. Total Body Water was normal. NICaS identified impending heart failure just before decompensation. See Figure 1 for patient’s first NICaS inspection report.
Based on NICaS inspection results, the cardiologist prescribe ACE Inhibitor. In addition, a low salt diet was recommended.
2 month later, the patients arrived to the cardiologist for a second visit. NICaS second inspection verified that afterload was reduced and contractility was improved, both in to normal range. The decompensation was prevented and could be that potential hospitalization was prevented. See Figure 2 for patient’s second NICaS inspection reports.